Michael Klichinsky
Founder bei CARISMA THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Michael Klichinsky is the founder.
He founded CTx Operations, Inc. in 2016 and holds the title of Chief Scientific Officer.
He also founded Carisma Therapeutics, Inc. in 2016 and holds the title of Chief Scientific Officer.
Dr. Klichinsky has a doctorate degree from the University of Pennsylvania and a doctorate degree from the University of the Sciences in Philadelphia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.01.2024 | 484 347 ( 1,20% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Michael Klichinsky
| Unternehmen | Position | Beginn |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Founder | 01.01.2016 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Founder | 01.01.2016 |
Ausbildung von Michael Klichinsky
| University of Pennsylvania | Doctorate Degree |
| University of the Sciences in Philadelphia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
